NFKB1 and nasopharyngeal carcinoma: We used Andro or Bay 11-7082 (a NF-κB inhibitor) to inhibit the transcriptional activity of NF-κB. Our results showed that NF-κB activation is required for NPC cell proliferation, invasion, and regulation of cell apoptosis and death.